Spiriva Respimat Now Available in Pharmacies for Asthma Patients – Pharmacy Times

Spiriva Respimat Now Available in Pharmacies for Asthma Patients
Pharmacy Times
“Despite taking other daily maintenance treatments, many people with asthma continue to experience symptoms, including coughing, wheezing, and shortness of breath,” said Michael Foggs, chief of allergy and immunology for the Advocate Medical Group at …

and more »

View full post on asthma – Google News

Effect of prenatal supplementation with vitamin D on asthma or recurrent wheezing in offspring by age 3 years – Pharmacy Today, American Pharmacists Association, pharmacist.com


JAMA: The Journal of the American Medical Association

Effect of prenatal supplementation with vitamin D on asthma or recurrent wheezing in offspring by age 3 years
Pharmacy Today, American Pharmacists Association, pharmacist.com
Lack of vitamin D during pregnancy can lead to breathing disorders early in a child's life. Researchers tested whether prenatal vitamin D supplementation could prevent asthma or recurrent wheezing by administering specific doses to 876 women aged …
Prenatal Vitamin D and Baby's Asthma RiskWebMD
Effect of Prenatal Supplementation With Vitamin D on Asthma or Recurrent Wheezing in Offspring by Age 3 Years: The JAMA: The Journal of the American Medical Association
Lower Asthma Risk From Prenatal Vitamin D Unconfirmed But Supplement Isn't a Bad Idea: ExpertsLatinos Health
EurekAlert (press release)
all 30 news articles »

View full post on asthma – Google News

New treatment for severe asthma – Pharmacy Today, American Pharmacists Association, pharmacist.com

New treatment for severe asthma
Pharmacy Today, American Pharmacists Association, pharmacist.com
In early November, FDA approved mepolizumab (Nucala—GlaxoSmithKline), a novel treatment for severe asthma. This new treatment is an interleukin-5 (IL-5) antagonist that works by inhibiting IL-5 signaling, with subsequent reduction in the production

View full post on asthma – Google News

Independent group says new Glaxo asthma drug far too expensive – Pharmacy Today, American Pharmacists Association, pharmacist.com

Independent group says new Glaxo asthma drug far too expensive
Pharmacy Today, American Pharmacists Association, pharmacist.com
The nonprofit analyzed the once-monthly injectable drug for severe asthma, finding that it should be priced at $7,800 to $12,000 a year, compared with the current list price of $32,500 a year. While the drug significantly reduces asthma attacks and

View full post on asthma – Google News

FDA advisers recommend approval of asthma drug for adults – Pharmacy Today, American Pharmacists Association, pharmacist.com

FDA advisers recommend approval of asthma drug for adults
Pharmacy Today, American Pharmacists Association, pharmacist.com
An FDA advisory committee has recommended the agency approve Teva Pharmaceutical's experimental drug reslizumab for severe asthma in patients aged 18 years and older. Reslizumab is an antibody drug designed to be given intravenously once every …

View full post on asthma – Google News